Some drugs used to treat various diseases can have a negative impact on bone health, causing their density and increasing risk of fractures.
According to an article published by the Washington Post, five categories of drugs require special attention because of possible impact on bone structure and sustainability.
Among them are oral cortichosteroids, such as prednisone, used to treat inflammation, allergies, asthma, and autoimmune diseases. Their use for long periods and high doses can prevent bone formation and accelerate loss of bone mass.
Another category is the inhibitors of the spices used in treating breast cancer. These drugs lower estrogen levels, a hormone that helps preserve bone density, thus increasing the risk of weakening them.
Even some anti-hypposis drugs, particularly phenobarbital, phennitoin, and carbamaphina, can affect bone health. They can lower vitamin D levels, making it difficult to absorb calcium from the organism.
The list also includes access to Androgenic deprivation ( ADT, used to treat prostate cancer. This therapy lowers testosterone levels, a hormone that helps preserve bone strength and muscle mass.
The fifth category is antidepressives known as seronton retakers ( SSRI, which is used in dealing with depression and anxiety. Some studies have linked these drugs to possible bone density and increased risk for fractures, although more research is needed.
Experts quoted by the Washington Post stress that using these drugs does not necessarily imply that treatment should be stopped.
Those using these drugs are advised to discuss with their doctor the potential danger, bone density checks, and the need to monitor calcium levels and vitamin D.
Physical activity that involves weight maintenance and endurance exercises can also help to maintain bone and muscle health.
Experts warn that no medicine will be interrupted without publicly consulting the doctor who has described it.
The signal where the truth speaks before the news!
Source Layer: Signal
